On April 27, 2021, Laura J. Wahlberg informed of her intent to resign from C4 Therapeutics, Inc. (“the company"), effective as of May 28, 2021. As of that date, Ms. Wahlberg will cease to serve in the role of Vice President, Finance, Corporate Controller and Principal Accounting Officer, and has agreed to provide transitional services after her departure under the terms of a consulting agreement.